Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma

BACKGROUND: Treatments based on the inhibition of pivotal signals of cancer stem cells (CSCs) are on a promising track. Recent studies have shown that targeting CSCs with broader immune‐based therapeutic methods, for example, the anti‐CD47 treatment, may serve as a more potent strategy for eliminati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Main Authors: Wang, Jian‐Hua, Huang, Shu‐Ting, Zhang, Lan, Liu, Zi‐Gang, Liang, Rong‐Xin, Jiang, Sen‐Wei, Jiang, Yi‐Nan, Yu, Xing‐Juan, Jiang, Yu‐Chuan, Li, Xi‐Zhao, Zhang, Pei‐Fen, Wen, Zhe‐Sheng, Zheng, Min
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Cancer Prevention
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6434369/
https://ncbi.nlm.nih.gov/pubmed/30741466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1894
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares